Protein kinase membrane-associated tyrosine/threonine 1 (PKMYT1), a member of the WEE family of kinases, has recently emerged as a potential druggable target in multiple cancers including PDAC (Yang et al., 2024). Here, PKMYT1 is linked to cancer.